LR-19051

N/A

Report date: 2024/11/04 16:56:56
NME

Base Information

Drug NameLR-19051
Drug Alias NameLR-19051
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailand
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesLG Chem Life Sciences Innovation Center Inc
China Registration ClassN/A

Develop Information

Active CompaniesLG Chem Life Sciences Innovation Center Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A